Elon Musk’s alleged drug use leaves his companies and their boards exposed to potential shareholder claims that directors’ and officers’ insurance is meant to cover.
Musk, the world’s richest person, has used recreational and illegal drugs in recent years—including LSD, cocaine, ecstasy, and psychedelic mushrooms—and has an active prescription for ketamine, according to a report from The Wall Street Journal.
Musk’s reported behavior carries risks for the board directors of
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.